6533b86cfe1ef96bd12c8b65

RESEARCH PRODUCT

Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease.

Giovanni SavettieriMarianna RioloValentina ArnaoPaolo Aridon

subject

medicine.medical_specialtyPathologyDura materRosai-Dorfmann disease mercaptopurine treatmentCase Reportlcsh:RC346-42903 medical and health sciences0302 clinical medicineCervical lymphadenopathymedicineExtranodal Involvementlcsh:Neurology. Diseases of the nervous systemRosai–Dorfman diseasebusiness.industrymedicine.diseaseDebulkingMercaptopurineHistiocytosismedicine.anatomical_structure030220 oncology & carcinogenesisOptic nerveRadiologymedicine.symptomGeneral Agricultural and Biological Sciencesbusiness030217 neurology & neurosurgerymedicine.drug

description

Background. Rosai-Dorfmann disease (RDD) is a rare, idiopathic non-Langerhans cell histiocytosis, affecting children and young adults, that commonly presents as painless, massive cervical lymphadenopathy with fever, weight loss, and polyclonal hypergammaglobulinemia. Cervical lymphadenopathy and extranodal involvement are the main presentations. On the contrary, ophthalmic involvement and localisation in the central nervous system are rare.Case Report. An old man was admitted to our hospital for first seizure. Brain imaging studies revealed on the left an extra-axial thickening of the dura mater with enhancement and perilesional oedema, infiltrating the sphenoorbital fissure and an isointense mass with enhancement in the orbital region with dislocation of the optic nerve. Pathological and immunohistochemistry examination of the bioptical specimen was consistent with a diagnosis of RDD. Treatment with levetiracetam and steroids was started obtaining only remission of seizures. Because of the patient refusal of the surgical debulking, therapy with mercaptopurine was started, stopping disease progression.Conclusion. So far, very few cases of extranodal RDD with multiple CNS lesions involving the orbital region have been described. Our case is significant because it is the first case in which the efficacy of mercaptopurine treatment has been documented in an adult patient with isolated ocular and intracranial RDD.

10.1155/2016/1030478http://hdl.handle.net/10447/214198